Andrew Kinloch

Associate Director (Platform Innovation) @ Ampersand Biomedicines

Country

United States

City

Cambridge

Industry

Biotechnology

Skill

confocal microscopy, proteomics, monoclonal antibody generation, Antigen Characterization, antibody screening, protein purification, serological assay development, ELISA development, Image Analysis, biomarker development, epitope mapping, image analysis, Antibodies, Rheumatoid Arthritis, Lupus, Screening, Assay Development, Research, SDS-PAGE, Western Blotting

Experience

Associate Director (Platform Innovation)

Ampersand Biomedicines

2024-9 - Present · 2 yrs 1 mo

Boston, Massachusetts, United States

Principal Scientist

Ampersand Biomedicines

2021-8 - 2024-9 · 3 yrs 2 mos

Boston, Massachusetts, United States

Principal Scientist (Platform Innovation)

Flagship Pioneering

2022-9 - 2024-9 · 2 yrs 1 mo

Boston, Massachusetts, United States

Senior Scientist (Platform Innovation)

Flagship Pioneering

2021-8 - 2022-8 · 1 yr 1 mo

Cambridge, Massachusetts, United States

Senior Scientist (Next Generation Platform Development)

Eutropics

2020-1 - 2021-7 · 1 yr 7 mos

Cambridge, MA

Leader of assay development and next generation platform development program, centered around the development and application of first in class mAbs specific for epitopes on heterodimeric complexes in the prediction of response to therapy in leukemia and solid tissue cancers.

Staff Scientist

University of Chicago

2015-1 - 2019-12 · 5 yrs

Development and application of technologies to aid characterizion of targets of patient derived monoclonal antibodies and secreted antibodies in body fluids during chronic inflammatory diseases